The results revealed that the two groups (high- vs. low-risk; high phenotypic enrichment) were mainly enriched in tumor- and immune-related pathways such as RIG-I-like receptor/P53/Toll-like signaling pathway and T-cell signaling pathway. The gene discussed is TLR4; the disease is neoplasm.